Cargando…

One‐year clinically important deterioration and long‐term clinical course in Japanese patients with COPD: a multicenter observational cohort study

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease with a complex progression of many clinical presentations, and clinically important deterioration (CID) has been proposed in the Western studies as a composite endpoint of disease progression. The aim of this study w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abe, Yuki, Suzuki, Masaru, Makita, Hironi, Kimura, Hirokazu, Shimizu, Kaoruko, Konno, Satoshi, Nishimura, Masaharu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117615/ https://www.ncbi.nlm.nih.gov/pubmed/33980194 http://dx.doi.org/10.1186/s12890-021-01510-w

Ejemplares similares

Serum Alpha-1 Antitrypsin Levels and the Clinical Course of Chronic Obstructive Pulmonary Disease
por: Takei, Nozomu, et al.
Publicado: (2019)

Annual Fractional Exhaled Nitric Oxide Measurements and Exacerbations in Severe Asthma
por: Abe, Yuki, et al.
Publicado: (2020)

Unique Mortality Profile in Japanese Patients with COPD: An Analysis from the Hokkaido COPD Cohort Study
por: Makita, Hironi, et al.
Publicado: (2020)

Annual Body Weight Change and Prognosis in Chronic Obstructive Pulmonary Disease
por: Abe, Yuki, et al.
Publicado: (2021)

Effect of Lung Volume on Airway Luminal Area Assessed by Computed Tomography in Chronic Obstructive Pulmonary Disease
por: Kambara, Kenta, et al.
Publicado: (2014)

Differential changes in quality of life components over 5 years in chronic obstructive pulmonary disease patients
por: Nagai, Katsura, et al.
Publicado: (2015)

A Comparative Evaluation of Computed Tomography Images for the Classification of Spirometric Severity of the Chronic Obstructive Pulmonary Disease with Deep Learning
por: Sugimori, Hiroyuki, et al.
Publicado: (2021)

Factors for the Variability of Three Acceptable Maximal Expiratory Flow–Volume Curves in Chronic Obstructive Pulmonary Disease
por: Yamamoto, Masafumi, et al.
Publicado: (2021)

Apoptosis inhibitor of macrophage (AIM)/CD5L is involved in the pathogenesis of COPD
por: Takimoto-Sato, Michiko, et al.
Publicado: (2023)

Relationship of annual change in bone mineral density with extent of emphysematous lesions and pulmonary function in patients with COPD
por: Goto, Kenichi, et al.
Publicado: (2018)

Annual change in FEV(1) in elderly 10-year survivors with established chronic obstructive pulmonary disease
por: Suzuki, Masaru, et al.
Publicado: (2019)

Large‐scale plasma proteomics can reveal distinct endotypes in chronic obstructive pulmonary disease and severe asthma
por: Suzuki, Masaru, et al.
Publicado: (2021)

Relationships of computed tomography-based small vessel indices of the lungs with ventilation heterogeneity and high transfer coefficients in non-smokers with asthma
por: Shimizu, Kaoruko, et al.
Publicado: (2023)

Central airway and peripheral lung structures in airway disease-dominant COPD
por: Tanabe, Naoya, et al.
Publicado: (2021)

Clinical Characteristics of Patients and Factors Associated with Switching Biologics in Asthma
por: Matsumoto-Sasaki, Machiko, et al.
Publicado: (2022)

Effects of obesity on CC16 and their potential role in overweight/obese asthma
por: Goudarzi, Houman, et al.
Publicado: (2022)

Prevention of clinically important deteriorations in COPD with umeclidinium/vilanterol
por: Singh, Dave, et al.
Publicado: (2016)

Anaplastic transformation of papillary thyroid carcinoma in multiple lung metastases presenting with a malignant pleural effusion: a case report
por: Abe, Tomoe, et al.
Publicado: (2014)

Clinical Characteristics and Outcomes of Patients with Asthma–COPD Overlap in Japanese Patients with COPD
por: Kobayashi, Seiichi, et al.
Publicado: (2020)

Familial multifocal micronodular pneumocyte hyperplasia with a novel splicing mutation in TSC1: Three cases in one family
por: Shoji, Tetsuaki, et al.
Publicado: (2019)

Composite endpoints in COPD: clinically important deterioration in the UPLIFT trial
por: Rabe, Klaus F., et al.
Publicado: (2020)

Measuring disease activity in COPD: is clinically important deterioration the answer?
por: Singh, Dave, et al.
Publicado: (2020)

Preventing clinically important deterioration with single-inhaler triple therapy in COPD
por: Naya, Ian, et al.
Publicado: (2018)

Prognostic value of clinically important deterioration in COPD: IMPACT trial analysis
por: Han, MeiLan K., et al.
Publicado: (2021)

Correction to: Measuring disease activity in COPD: is clinically important deterioration the answer?
por: Singh, Dave, et al.
Publicado: (2021)

Lung metastasis from gastric cancer presenting as diffuse ground-glass opacities
por: Abe, Yuki, et al.
Publicado: (2020)

Neural respiratory drive predicts clinical deterioration and safe discharge in exacerbations of COPD
por: Suh, Eui-Sik, et al.
Publicado: (2015)

Clinical Management and Outcomes of Patients With Portopulmonary Hypertension Enrolled in the Japanese Multicenter Registry
por: Tamura, Yudai, et al.
Publicado: (2022)

Clinical characteristics and outcomes in Japanese patients with COPD according to the 2017 GOLD classification: the Ishinomaki COPD Network Registry
por: Kobayashi, Seiichi, et al.
Publicado: (2018)

Genetic variants in mannose receptor gene (MRC1) confer susceptibility to increased risk of sarcoidosis
por: Hattori, Takeshi, et al.
Publicado: (2010)

Neutrophil predominance in bronchoalveolar lavage fluid is associated with disease severity and progression of HRCT findings in pulmonary Mycobacterium avium infection
por: Inomata, Takashi, et al.
Publicado: (2018)

Resting hyperinflation and emphysema on the clinical course of COPD
por: Kim, Yeon Wook, et al.
Publicado: (2019)

Long-term outcomes following first short-term clinically important deterioration in COPD
por: Naya, Ian P., et al.
Publicado: (2018)

Real-World Evidence on the Diagnostic and Clinical Characteristics of Asthma in Japanese Patients with COPD: The ACO Japan Cohort Study
por: Hashimoto, Shu, et al.
Publicado: (2023)

Tiotropium/olodaterol versus tiotropium in Japanese patients with COPD: results from the DYNAGITO study
por: Ichinose, Masakazu, et al.
Publicado: (2018)

The effect of indacaterol/glycopyrronium versus tiotropium or salmeterol/fluticasone on the prevention of clinically important deterioration in COPD
por: Anzueto, Antonio R, et al.
Publicado: (2017)

How exercise can deteriorate the clinical course of an ARVC patient: a case report
por: Lüsebrink, Enzo, et al.
Publicado: (2021)

Analyses of natural courses of Japanese patients with Alzheimer's disease using placebo data from placebo-controlled, randomized clinical trials: Japanese Study on the Estimation of Clinical course of Alzheimer's disease
por: Watanabe, Mitsunori, et al.
Publicado: (2019)

The impact of coronavirus disease 2019 (COVID-19) in Japanese companion animal clinics
por: FUKUMOTO, Fuka, et al.
Publicado: (2022)

Cognitive and Functional Deterioration in Patients with Severe COPD(1)
por: Özge, Cengiz, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_r02kq9lnvasuc2h7a5tppahigg